Response to Peginterferon-alfa 2b and Ribavirin in Japanese Patients with Chronic Hepatitis C Genotype 2-Reference-Cited by-同舟云学术

Response to Peginterferon-alfa 2b and Ribavirin in Japanese Patients with Chronic Hepatitis C Genotype 2

Published:2011-05-22 Issue:11 Volume:56 Page:3335-3342
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Kanda Tatsuo,Imazeki Fumio,Azemoto Ryosaku,Yonemitsu Yutaka,Mikami Shigeru,Kita Kazuhiko,Takashi Motohide,Sunaga Masahiko,Wu Shuang,Nakamoto Shingo,Tawada Akinobu,Arai Makoto,Kato Keizo,Yoshida Yu,Koma Yoshihiro,Fujiwara Keiichi,Fukai Kenichi,Suzuki Noriaki,Yokosuka Osamu

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-011-1750-7.pdf

Reference25 articles.

1. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975–982.

2. McHutchison JG, Poynard T. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C. Semin Liver Dis. 1999;19:57–65.

3. Di Bisceglie AM, Hoofnagle JH. Optimal therapy of hepatitis C. Hepatology. 2002;36:S121–S127.

4. Manns M, Zeuzem S, Sood A, et al. Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C. J Hepatol. 2011/01/12.

5. Diago M, Shiffman ML, Bronowicki JP, et al. Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40 kDa) plus ribavirin. Hepatology. 2010;51:1897–1903.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A retrospective study of the efficacy of sofosbuvir plus NS5A inhibitors for patients with hepatitis C virus genotype-2 chronic infection;European Journal of Gastroenterology & Hepatology;2019-03

2. No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its Vicinity;Internal Medicine;2019-02-15

3. History of Treatment for Hepatitis C - In the Era When Cure Is Achieved with Oral Drugs -;Juntendo Medical Journal;2019

4. Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study;Clinical and Molecular Hepatology;2018-09-25

5. Predictors of treatment efficacy and ALT non-normalization with sofosbuvir/ribavirin therapy for patients with hepatitis C virus genotype 2;Journal of Medical Virology;2017-05-23